Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy

AIM: To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin/MATERIAL AND METHODS: 107 patients (57 women and 50 men) aged...

Full description

Bibliographic Details
Main Authors: F U Dzgoeva, T M Gatagonova, Z K Kadzaeva, O V Khamitsaeva, Z Kh Kochisova, A T Dzutseva, B G Bazaeva, T L Bestaeva
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-06-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31283
_version_ 1818524371716669440
author F U Dzgoeva
T M Gatagonova
Z K Kadzaeva
O V Khamitsaeva
Z Kh Kochisova
A T Dzutseva
B G Bazaeva
T L Bestaeva
author_facet F U Dzgoeva
T M Gatagonova
Z K Kadzaeva
O V Khamitsaeva
Z Kh Kochisova
A T Dzutseva
B G Bazaeva
T L Bestaeva
author_sort F U Dzgoeva
collection DOAJ
description AIM: To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin/MATERIAL AND METHODS: 107 patients (57 women and 50 men) aged 22 to 63 years with ESRF were examined. The follow-up was 18 months. LV ejection fraction, peak early diastolic filling rate, peak late diastolic filling rate, their ratio, LV isovolumic relaxation time, LV end-diastolic diameter, LV end-diastolic volume, LV end-diastolic diameter index (EDDI), LV posterior wall and ventricular septal thickness, and LV mass index were determined. J. Gottdiener's classification based on the calculation of EDDI and LV relative wall thickness was used to estimate LV geometry. Erythropoietin was given to patients with the baseline level of hemoglobin (Hb)
first_indexed 2024-12-11T05:56:10Z
format Article
id doaj.art-4b773c08497f4a86985f7b2eb4f9d5d9
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-11T05:56:10Z
publishDate 2013-06-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-4b773c08497f4a86985f7b2eb4f9d5d92022-12-22T01:18:40Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422013-06-01856445028299Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapyF U DzgoevaT M GatagonovaZ K KadzaevaO V KhamitsaevaZ Kh KochisovaA T DzutsevaB G BazaevaT L BestaevaAIM: To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin/MATERIAL AND METHODS: 107 patients (57 women and 50 men) aged 22 to 63 years with ESRF were examined. The follow-up was 18 months. LV ejection fraction, peak early diastolic filling rate, peak late diastolic filling rate, their ratio, LV isovolumic relaxation time, LV end-diastolic diameter, LV end-diastolic volume, LV end-diastolic diameter index (EDDI), LV posterior wall and ventricular septal thickness, and LV mass index were determined. J. Gottdiener's classification based on the calculation of EDDI and LV relative wall thickness was used to estimate LV geometry. Erythropoietin was given to patients with the baseline level of hemoglobin (Hb)https://ter-arkhiv.ru/0040-3660/article/view/31283end-stage renal failurediastolic dysfunctionleft ventricular hypertrophyanemiaerythropoietin
spellingShingle F U Dzgoeva
T M Gatagonova
Z K Kadzaeva
O V Khamitsaeva
Z Kh Kochisova
A T Dzutseva
B G Bazaeva
T L Bestaeva
Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
Терапевтический архив
end-stage renal failure
diastolic dysfunction
left ventricular hypertrophy
anemia
erythropoietin
title Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
title_full Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
title_fullStr Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
title_full_unstemmed Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
title_short Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
title_sort diastolic dysfunction in different types of left ventricular hypertrophy in patients with end stage renal failure impact of long term erythropoietin therapy
topic end-stage renal failure
diastolic dysfunction
left ventricular hypertrophy
anemia
erythropoietin
url https://ter-arkhiv.ru/0040-3660/article/view/31283
work_keys_str_mv AT fudzgoeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT tmgatagonova diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT zkkadzaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT ovkhamitsaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT zkhkochisova diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT atdzutseva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT bgbazaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy
AT tlbestaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy